Latest Breaking News On - Biologics company profile - Page 6 : comparemela.com

ADMA Biologics, Inc. (NASDAQ:ADMA – Get Free Report) Director Young Kwon acquired 25,000 shares of ADMA Biologics stock in a transaction on Thursday, August 24th. The shares were bought at an average cost of $3.90 per share, for a total transaction of $97,500.00. Following the completion of the transaction, the director now owns 277,401 shares […]

United statesKyoung kwonConnor clark lunn investment management ltdAdma biologics incSecurities exchange commissionBiologics company profileCantor fitzgeraldCapital partnersBiologics incElevate incGet free reportDirector young kwonExchange commissionStock downLunn investment managementCaligan partners